Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/26/2010WO2010096384A2 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands
08/26/2010WO2010096382A1 Processes for the production of proteins containing selenium using yeast cells
08/26/2010WO2010096371A2 Heterocyclic compounds which modulate the cb2 receptor
08/26/2010WO2010096338A1 PYRAZOLO [4,3-c] CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
08/26/2010WO2010096314A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS
08/26/2010WO2010096302A1 Hepatitis c virus inhibitors
08/26/2010WO2010096231A1 Policosanol nanoparticles
08/26/2010WO2010096201A2 Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeutics, diagnostics, g- tetrad forming oligonucleotides and aptamers
08/26/2010WO2010096170A2 Inhibition of trna synthetases and therapeutic applications thereof
08/26/2010WO2010096123A2 Amino acid salts of prostaglandins
08/26/2010WO2010096068A1 Controlled release budesonide minitablets
08/26/2010WO2010096067A1 Controlled release budesonide minitablets
08/26/2010WO2010096051A1 6,11-bicyclolides: bridged biaryl amide macrolide derivatives
08/26/2010WO2010096045A1 Novel and potent tapentadol dosage forms
08/26/2010WO2010096011A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
08/26/2010WO2010095965A1 The use of sulindac and/or its metabolite as adjuvant treatment for colon cancer in humans
08/26/2010WO2010095964A1 A method for amphiphilic drug loading in liposomes by ion gradient
08/26/2010WO2010095943A2 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning
08/26/2010WO2010095926A1 Use of reveratrol for preserving cognitive functioning
08/26/2010WO2010095858A2 Pharmaceutical composition containing rhei rhizoma extract, fractions thereof, or stilbene-based compounds for preventing or treating diseases mediated by intercellular adhesion molecule-1
08/26/2010WO2010095768A1 4 -isopropylphenyl glucitol compounds as sgltl inhibitors
08/26/2010WO2010095767A1 Pyrimidin-4(3h)-one derivatives
08/26/2010WO2010095766A1 1,4-benzodiazepin-2-on derivatives
08/26/2010WO2010095714A1 Novel compounds and binding inhibitors, anti-allergic agents, anti-asthmatic agents and anti-inflammatory agents
08/26/2010WO2010095706A1 Novel anti-inflammatory compounds
08/26/2010WO2010095690A1 Blood flow improving agent
08/26/2010WO2010095663A1 Fused heterocyclic ring compound
08/26/2010WO2010095537A1 Transdermal preparation
08/26/2010WO2010095494A1 Granules containing poorly soluble substance, tablet, and method for solubilizing poorly soluble substance
08/26/2010WO2010095478A1 Sustainedly drug-releasing hydrogel contact lens, and drug releasing method using sustainedly drug-releasing hydrogel contact lens
08/26/2010WO2010095462A1 Novel compounds comprising a 3-(5-alkoxypyrimidin-2-yl) pyrimidin-4(3h)-one structure and drugs that comprise same
08/26/2010WO2010095455A1 Hypo-immunogenic streptavidin and use thereof
08/26/2010WO2010095428A1 Foxm1 peptides and vaccines containing the same
08/26/2010WO2010095425A1 Method for producing crystals of vitamin d derivative
08/26/2010WO2010095364A1 Jarid1b for target gene of cancer therapy and diagnosis
08/26/2010WO2010095304A1 Hydrogel of polysaccharide derivatives
08/26/2010WO2010095227A1 Novel compound, and binding inhibitor, anti-allergic agent, anti-asthma agent and anti-inflammatory agent
08/26/2010WO2010095158A1 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
08/26/2010WO2010095145A1 Process for the preparation of voriconazole
08/26/2010WO2010095106A1 Solid forms of ( 2r) -2- { ( is ) -6, 7 -dimethoxy- 1- [2- (4-triflu0r0methyl-phenyl) -ethyl] -3, 4-dihydr0-1h -isoquinolin-2-yl} -n-methyl-2-phenyl-acetamide hydrochloride
08/26/2010WO2010095091A1 A process to make fusidic acid cream
08/26/2010WO2010095090A1 A dermaceutical gel made using sodium fusidate & a process to make it
08/26/2010WO2010095067A1 Dispersion of phytosterols
08/26/2010WO2010095042A2 Pyridocarbazole type compounds and applications thereof
08/26/2010WO2010095041A2 Compositions, methods, and kits for treating influenza viral infections
08/26/2010WO2010094996A1 Oral pharmaceutical composition for use in respiratory diseases
08/26/2010WO2010094986A1 Micronized carotenoid preparation as immunostimulant for crustaceans
08/26/2010WO2010094977A1 Novel biphenyl compounds useful for the treatment of hepatitis c
08/26/2010WO2010094964A1 Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
08/26/2010WO2010094956A1 Triazolopyridine derivatives as p38 map kinase inhibitors
08/26/2010WO2010094899A1 Nucleic acids specifically binding with human factor vii/viia and uses thereof
08/26/2010WO2010094821A1 Use of vaginally-administered insulin sensitizing agents
08/26/2010WO2010094810A1 Pharmaceutical compositions and methods for treating tuberculosis
08/26/2010WO2010094792A1 Emergency kit for producing a drug for nasal administration of opioids in the event of respiratory distress
08/26/2010WO2010094762A1 Heteroaryl substituted pyridazinone derivatives
08/26/2010WO2010094760A1 Cajanus extracts and glucosamine for inflammatory disorders
08/26/2010WO2010094755A1 Carboxamide compounds and their use as calpain inhibitors
08/26/2010WO2010094745A1 Hydrolysate of crocin
08/26/2010WO2010094738A1 Phosphate ester of a 4-pyridone derivative and its use in the chemotherapy of parasitic infections
08/26/2010WO2010094734A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
08/26/2010WO2010094733A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
08/26/2010WO2010094732A1 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
08/26/2010WO2010094721A1 Piperidin-pyrimidine derivatives as antagonists of histamine h4 receptor
08/26/2010WO2010094695A1 Pyrimido [5,4-d] pyrimidine derivatives for the inhibition of tyrosine kinases
08/26/2010WO2010094693A1 Glycolipid mixture with antiinflammatory acivity obtained from oscillatoria planktothrix
08/26/2010WO2010094678A1 Novel ortho-aminoamides for the treatment of cancer
08/26/2010WO2010094669A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
08/26/2010WO2010094667A1 Pyrrolidine derivatives as nk3 receptor antagonists
08/26/2010WO2010094659A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010WO2010094647A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
08/26/2010WO2010094645A1 Substituted pyridine derivatives and their medical use
08/26/2010WO2010094644A1 Substituted pyridine derivatives and their medical use
08/26/2010WO2010094643A1 Quinoline derivatives and their uses for rhinitis and urticaria
08/26/2010WO2010094624A1 Particles comprising drospirenone encapsulated in a polymer
08/26/2010WO2010094623A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration
08/26/2010WO2010094622A1 3, 3' -spiroindolinone derivatives as anticancer agents
08/26/2010WO2010094609A1 Pharmaceutical composition containing inhibiting agents of protein methyltransferase i and use thereof to treat tumor diseases
08/26/2010WO2010094535A1 Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives
08/26/2010WO2010094499A1 Methods and compositions for diagnosis and treatment of cancer
08/26/2010WO2010094491A1 Means for inhibiting the expression of ang2
08/26/2010WO2010094484A1 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases
08/26/2010WO2010094483A1 5- (2-{ [6- (2, 2-difluoro-2-phenylethoxy) hexyl] amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (ih)-one for the treatment of lung function
08/26/2010WO2010094471A1 Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
08/26/2010WO2010094452A2 Novel composition
08/26/2010WO2010094405A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
08/26/2010WO2010094289A1 Allosteric binding compounds
08/26/2010WO2010094242A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
08/26/2010WO2010094218A1 Oral spray or aerosol of palonosetron
08/26/2010WO2010094130A1 Carbohydrate-metallocene-antimalarial conjugates
08/26/2010WO2010094126A1 Heterocyclic derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010WO2010094120A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/26/2010WO2010094074A1 Pharmaceutical preparation and delivery system
08/26/2010WO2010080563A3 Method for treating macular degeneration
08/26/2010WO2010079513A3 Medicament for painless treatment of warts, corns and callus
08/26/2010WO2010078486A3 Opioid-containing oral pharmaceutical compositions and methods
08/26/2010WO2010077883A3 Antagonists of lysophosphatidic acid receptors
08/26/2010WO2010076524A3 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators
08/26/2010WO2010076033A9 Toluidine sulfonamides and their use
08/26/2010WO2010073104A3 Improving cognitive function
08/26/2010WO2010066682A4 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
1 ... 2115 2116 2117 2118 2119 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 ... 7860